Biotech: Pressemitteilungen - Kategorie - Seite 98

Biotech

Category / Pharmaceuticals & Biotech / Biotech


Immunovaccine Receives Conditional Approval to Graduate to Toronto Stock Exchange (TSX)

HALIFAX, NOVA SCOTIA: Shares to be Listed Under Symbol "IMV" on Canada's Senior Stock Exchange ...

Horizon Pharma plc Announces Favorable Markman Ruling in RAYOS(R) (prednisone) Delayed-Release Tablets Patent Infringement Litigation

DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 11/12/14 -- Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company with a portfolio of products in arthritis, inflammation and orphan diseases, t ...

Horizon Pharma plc to Present at the Stifel 2014 Healthcare Conference

DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 11/11/14 -- Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company with a portfolio of products in arthritis, inflammation and orphan diseases, t ...

Coverage Initiation Report Focuses on Oramed Pharmaceuticals

NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 11/11/14 -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) is the subject of a new in-depth initiation coverage repot by Acceleron Equity Research.Interested investor may ...

Global Biopharmaceutical Company UCB Expands Real Estate Services Relationship With JLL

LONDON, UNITED KINGDOM: LONDON, UNITED KINGDOM -- (Marketwired) -- 11/11/14 -- Brussels-based biopharmaceutical company UCB has renewed a three year global real estate services agreement with JLL (NYSE: JLL).The agreement s ...

MYOS Corporation to Announce Third Quarter 2014 Financial Results and Host Conference Call on November 14, 2014

CEDAR KNOLLS, NJ: Conference Call and Webcast Scheduled for Friday, November 14, 2014 at 10:00 a.m. ET ...

Threshold Pharmaceuticals Receives FDA Fast Track Designation for TH-302 for the Treatment of Previously Untreated Patients With Metastatic or Locally Advanced Unresectable Soft Tissue Sarcoma

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 11/11/14 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation ...

Titan Pharmaceuticals Appoints Two New Board Members

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 11/11/14 -- (OTCBB: TTNP) announced today that it has appointed life sciences industry veterans Joseph A. Akers and James McNab Jr. to its board of direct ...

Patient Enrollment in Cellceutix Phase 2 Clinical Trial of Brilacidin-OM for Oral Mucositis Targeted to Begin in December 2014

BEVERLY, MA: BEVERLY, MA -- (Marketwired) -- 11/11/14 -- Cellceutix Corporation (OTCQB: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology, d ...

ProMetic's PBI-4050 Cleared to Commence Clinical Trials in Patients with Diabetic Kidney Disease

LAVAL, QUEBEC: - Clinical Trial Application ("CTA") clearance received from Health Canada - Enrollment of first patients to begin this month ...

Avita Medical Announces Receipt of $1.4 Million R&D Tax Incentive

NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM: NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM -- (Marketwired) -- 11/11/14 -- Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY) a regenerative medicine company specializing in the treatment of wounds and s ...

Alchemia Announces Departure of Chief Executive Officer

BRISBANE, AUSTRALIA: BRISBANE, AUSTRALIA -- (Marketwired) -- 11/10/14 -- Alchemia Limited, (ASX: ACL) a drug discovery and development company, today announced the departure of Thomas Liquard as Chief Executive Officer.I ...

Kadmon Corporation Researchers Define Importance of ROCK2 Signaling Pathway in Human Autoimmune Response

NEW YORK, NY: Data Published in Proceedings of the National Academy of Sciences; Results Suggest Role for ROCK2 Inhibition in Autoimmunity Treatment ...

iBio Grants Caliber License for Production of Antibodies Targeting Ebola

NEWARK, DE: NEWARK, DE -- (Marketwired) -- 11/10/14 -- iBio, Inc. (NYSE MKT: IBIO) and Caliber Biotherapeutics LLC executed an agreement, effective today, for an emergency use license to the iBioLaunch™ platfo ...

AntriaBio Extinguishes $44 Million Contingent Liability

LOUISVILLE, CO: LOUISVILLE, CO -- (Marketwired) -- 11/10/14 -- (OTCQB: ANTB), a biopharmaceutical corporation focused on developing novel extended release therapies, announced today that it has successfully extingu ...

Phase II Clinical Data Presented at SITC Annual Meeting Support Immunotherapeutic Mechanism of Action of Peregrine Pharmaceuticals' Bavituximab in Liver Cancer

TUSTIN, CA: Combination of Bavituximab and Sorafenib in Patients With Advanced Liver Cancer Resulted in Increased Cytotoxic T-cell Activation and Other Immune Responses Within Tumors Which Positively Correlated W ...

Threshold Pharmaceuticals Announces Presentation and Webcast at the Stifel 2014 Healthcare Conference

SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 11/10/14 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Barry Selick, Ph.D., Threshold's Chief Executive Officer, will present ...

Sernova Provides Corporate Update

LONDON, ONTARIO: Advances Made in Cell Pouch(TM) Clinical Development and Positive Outlook for Company's New Therapeutic Cell Technologies ...

Dynavax Announces One-for-Ten Reverse Stock Split

BERKELEY, CA: BERKELEY, CA -- (Marketwired) -- 11/07/14 -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that it had completed a one-for-ten reverse split of its common stock, effective as of 5:0 ...


Seite 98 von 255:  « ..  97 98 99  100  101  102  103  104  105  106  .. » 255





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z